These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23363487)
21. Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Tang LWT; DaSilva E; Lapham K; Obach RS Drug Metab Dispos; 2024 May; 52(6):565-573. PubMed ID: 38565303 [TBL] [Abstract][Full Text] [Related]
22. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition. Hamzeh-Mivehroud M; Rahmani S; Feizi MA; Dastmalchi S; Rashidi MR Arch Pharm (Weinheim); 2014 Oct; 347(10):738-47. PubMed ID: 24956178 [TBL] [Abstract][Full Text] [Related]
24. Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. Manevski N; King L; Pitt WR; Lecomte F; Toselli F J Med Chem; 2019 Dec; 62(24):10955-10994. PubMed ID: 31385704 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance. Ekins S; Obach RS J Pharmacol Exp Ther; 2000 Nov; 295(2):463-73. PubMed ID: 11046077 [TBL] [Abstract][Full Text] [Related]
26. A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes. Akabane T; Gerst N; Masters JN; Tamura K Xenobiotica; 2012 Sep; 42(9):863-71. PubMed ID: 22448773 [TBL] [Abstract][Full Text] [Related]
27. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes. Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625 [TBL] [Abstract][Full Text] [Related]
28. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches. Mahmood I Drug Metabol Drug Interact; 2002; 19(1):49-64. PubMed ID: 12222754 [TBL] [Abstract][Full Text] [Related]
29. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686 [TBL] [Abstract][Full Text] [Related]
30. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938 [TBL] [Abstract][Full Text] [Related]
31. Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human. Hosogi J; Ohashi R; Maeda H; Tashiro S; Fuse E; Yamamoto Y; Kuwabara T Drug Metab Pharmacokinet; 2017 Oct; 32(5):255-264. PubMed ID: 28751116 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping. Yang X; Johnson N; Di L J Pharm Sci; 2019 Apr; 108(4):1627-1630. PubMed ID: 30448524 [TBL] [Abstract][Full Text] [Related]
33. A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834. Sodhi JK; Wong S; Kirkpatrick DS; Liu L; Khojasteh SC; Hop CE; Barr JT; Jones JP; Halladay JS Drug Metab Dispos; 2015 Jun; 43(6):908-15. PubMed ID: 25845827 [TBL] [Abstract][Full Text] [Related]
34. Aldehyde oxidase and its importance in novel drug discovery: present and future challenges. Garattini E; Terao M Expert Opin Drug Discov; 2013 Jun; 8(6):641-54. PubMed ID: 23565746 [TBL] [Abstract][Full Text] [Related]
35. Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate. Li AC; Cui D; Yu E; Dobson K; Hellriegel ET; Robertson P Xenobiotica; 2019 Mar; 49(3):302-312. PubMed ID: 29473769 [TBL] [Abstract][Full Text] [Related]
36. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Kosugi Y; Hosea N Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525 [TBL] [Abstract][Full Text] [Related]
37. Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs. Subash S; Singh DK; Ahire DS; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Smith BJ; Heyward S; Cronin CN; Prasad B Drug Metab Dispos; 2023 Oct; 51(10):1362-1371. PubMed ID: 37429730 [TBL] [Abstract][Full Text] [Related]
38. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532 [TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of molybdenum cofactor deficiency by assay of sulphite oxidase activity in chorionic villus samples. Johnson JL; Rajagopalan KV; Lanman JT; Schutgens RB; van Gennip AH; Sorensen P; Applegarth DA J Inherit Metab Dis; 1991; 14(6):932-7. PubMed ID: 1779653 [TBL] [Abstract][Full Text] [Related]
40. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Hutzler JM; Obach RS; Dalvie D; Zientek MA Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):153-68. PubMed ID: 23231678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]